The under use of thromboprophylaxis in older medical in-patients: A regional audit

QJM: An International Journal of Medicine

Volumn 100, Issue 11, 2007, Pages 685-689

  South, A ^a   Iveson, E ^b   Allgar, V ^c   Harbison, J ^d  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b YORK HOSPITAL   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; CHEMOPROPHYLAXIS; CHI SQUARE TEST; COMPRESSION THERAPY; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HIGH RISK PATIENT; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNITED KINGDOM; VENOUS THROMBOEMBOLISM;

EID: 35748956432     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm085     Document Type: Article

References (10)

1. Cohen AT, Alikhan R. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med 2001; 7:332-7.
2. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107(suppl. 1):14-8.
3. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep venous thrombosis? J R Soc Med 1989; 82:203-5.
4. Scottish Intercollegiate Guidelines Network (SIGN). Prophylaxis of Venous Thromboembolism. A National Clinical Guideline (2002). [http://www.sign.ac.uk/pdf/sign62.pdf]
5. Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than withholding treatment. Chest 2000; 118:1680-4.
6. Mismetti P, Laporte-Simitsidis S, Tardy B, Cucherat M, Buchmuller A, Juillard-Delsart D, Descousus H. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: meta-analysis of randomised clinical trials. Thromb Haemost 2000; 83:14-19.
7. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 338-400.
8. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of Deep Vein Thrombosis and Pulmonary Embolism: A 25 year Population Based Study. Archives of Internal Medicine 1998; 158:585-93.
9. Rashid ST, Thursz MR, Razvi NA, Voller R, Orchard T, Rashid ST, Shlebak AA. Venous thromboprophylaxis in UK medical inpatients. J R Soc Med 2005; 98:507-12.
10. Noble SIR, Nelson A, Turner C, Finlay IG. Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: Qualitative study. Br Med J 2006; 322:577-9.